Based on the Healixa Inc stock forecast from 0 analysts, the average analyst target price for Healixa Inc is not available over the next 12 months. Healixa Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Healixa Inc is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, Healixa Inc’s stock price was USD 0.05. Healixa Inc’s stock price has changed by -12.89% over the past week, -28.57% over the past month and -80.00% over the last year.
No recent analyst target price found for Healixa Inc
No recent average analyst rating found for Healixa Inc
Frequently Asked Questions About Healixa Inc (EMOR) Stock
Stock Target Advisor's fundamental analysis for Healixa Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on EMOR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on EMOR's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on EMOR's stock to indicate if its overvalued.
The last closing price of EMOR's stock was USD 0.05.
Unfortunately we do not currently have any market capitalization data for EMOR's stock.
Unfortunately we do not have enough analyst data on EMOR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Healixa Inc's stock.
Sorry, we do not have any data on the number of employees for Healixa Inc.
Sorry we do not have any infomation available on Healixa Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About Healixa Inc (EMOR) Stock
Stock Target Advisor's fundamental analysis for Healixa Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on EMOR's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on EMOR's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on EMOR's stock to indicate if its overvalued.
The last closing price of EMOR's stock was USD 0.05.
Unfortunately we do not currently have any market capitalization data for EMOR's stock.
Unfortunately we do not have enough analyst data on EMOR's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Healixa Inc's stock.
Sorry, we do not have any data on the number of employees for Healixa Inc.
Sorry we do not have any infomation available on Healixa Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EMOR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
